An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Bristol-Myers Squibb
Bristol-Myers Squibb
Children's Oncology Group
Fred Hutchinson Cancer Center
University of Washington
OHSU Knight Cancer Institute
Amgen
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute